Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
According to KFF, which specializes in health-related research, only about 1% of marketplace plans cover GLP-1 drugs solely for weight loss treatment
Updated 2026 Mar 23
Injectable weight-management therapies may be discussed for individuals experiencing: Difficulty losing weight despite diet and exercise Weight-loss plateaus Slower metabolism Increased appetite or frequent cravings The need for additional support during a weight-loss program A consultation helps determine which approach may best support your individual needs
Granted, this is ultimately a subjective measure, but there were some unanimous findings among our testers that could easily sway your decision
For example, ACE inhibtors carry a risk of harm if used during pregnancy as a boxed warning
Emerging frontiers in GLP-1 therapeutics: A comprehensive evidence base (2025)
